Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2018709116
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018709116
Title / Product Name
KONTINUIERLICHER VERABREICHUNG VON EXENATID UND CO-VERABREICHUNG VON ACETAMINOPHEN, ETHINYLESTRADIOL ODER LEVONORGESTREL
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2018709116
EP Publication Number
3565580
E-Number
1662828
Language
EN
PCT Number
US18012204
Publication Date
13.11.2019 A
06.03.2024 B1
Registration Date
06.03.2024
AT Publication Date
15.03.2024
Application Date
03.01.2018
Registration Number
-
Priorities
03.01.2017
US
201762441833 P
IPC
A61K 38/26 20060101AFI20180713BHEP
Maximum Duration of Protection
03.01.2038
Owner
i2o Therapeutics, Inc.
700 Main Street
Cambridge, MA 02139
US
Representative
No representatives present
Inventor
BARON, Michelle
One Marina Park Drive 13th Floor
Boston, MA 02210
US
YOUNG, Andrew
One Marina Park 13th Floor
Boston, MA 02210
US